| Year |
Citation |
Score |
| 2024 |
Bernal YA, Durán E, Solar I, Sagredo EA, Armisén R. ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer. International Journal of Molecular Sciences. 25. PMID 39000531 DOI: 10.3390/ijms25137424 |
0.693 |
|
| 2024 |
Bernal YA, Blanco A, Sagredo EA, Oróstica K, Alfaro I, Marcelain K, Armisén R. A Comprehensive Analysis of the Effect of A>I(G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer. Biomedicines. 12. PMID 38672084 DOI: 10.3390/biomedicines12040728 |
0.709 |
|
| 2022 |
Morales F, Pérez P, Tapia JC, Lobos-González L, Herranz JM, Guevara F, de Santiago PR, Palacios E, Andaur R, Sagredo EA, Marcelain K, Armisén R. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells. Gene. 819: 146246. PMID 35122924 DOI: 10.1016/j.gene.2022.146246 |
0.694 |
|
| 2020 |
Dufey E, Bravo-San Pedro JM, Eggers C, González-Quiroz M, Urra H, Sagredo AI, Sepulveda D, Pihán P, Carreras-Sureda A, Hazari Y, Sagredo EA, Gutierrez D, Valls C, Papaioannou A, Acosta-Alvear D, et al. Genotoxic stress triggers the activation of IRE1α-dependent RNA decay to modulate the DNA damage response. Nature Communications. 11: 2401. PMID 32409639 DOI: 10.1038/S41467-020-15694-Y |
0.747 |
|
| 2020 |
Sagredo EA, Sagredo AI, Blanco A, De Santiago PR, Rivas S, Assar R, Pérez P, Marcelain K, Armisén R. ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response. Biochimica Et Biophysica Acta. Molecular Cell Research. 118716. PMID 32275931 DOI: 10.1016/J.Bbamcr.2020.118716 |
0.73 |
|
| 2020 |
Cappelli C, Sepulveda H, Rivas S, Pola V, Urzúa U, Donoso G, Sagredo E, Carrero D, Casanova-Ortiz E, Sagredo A, González M, Manterola M, Nardocci G, Armisén R, Montecino M, et al. Ski Is Required for Tri-Methylation of H3K9 in Major Satellite and for Repression of Pericentromeric Genes: Mmp3, Mmp10 and Mmp13, in Mouse Fibroblasts. Journal of Molecular Biology. PMID 32198114 DOI: 10.1016/J.Jmb.2020.03.013 |
0.68 |
|
| 2018 |
Sagredo AI, Sagredo EA, Pola V, Echeverría C, Andaur R, Michea L, Stutzin A, Simon F, Marcelain K, Armisén R. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines. Journal of Cellular Physiology. PMID 30343491 DOI: 10.1002/Jcp.27371 |
0.747 |
|
| 2018 |
Sagredo EA, Blanco A, Sagredo AI, Pérez P, Sepúlveda-Hermosilla G, Morales F, Müller B, Verdugo R, Marcelain K, Harismendy O, Armisén R. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer. Biological Research. 51: 36. PMID 30290838 DOI: 10.1186/S40659-018-0185-4 |
0.697 |
|
| 2017 |
Sagredo AI, Sagredo EA, Cappelli C, Báez P, Rodrigo AM, Blanco C, Tapia JC, Echeverría C, Cerda O, Stutzin A, Simon F, Marcelain K, Armisén R. TRPM4 regulates Akt/GSK3-β activity and enhances β-catenin signaling and cell proliferation in prostate cancer cells. Molecular Oncology. PMID 28614631 DOI: 10.1002/1878-0261.12100 |
0.685 |
|
| Show low-probability matches. |